Free Trial

MetLife (MET) Stock Price, News & Analysis

MetLife logo
$86.83 +0.94 (+1.09%)
Closing price 01/17/2025 03:59 PM Eastern
Extended Trading
$87.21 +0.38 (+0.44%)
As of 08:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About MetLife Stock (NYSE:MET)

Key Stats

Today's Range
$85.87
$87.39
50-Day Range
$78.79
$88.25
52-Week Range
$64.61
$89.05
Volume
5.17 million shs
Average Volume
2.48 million shs
Market Capitalization
$60.12 billion
P/E Ratio
17.51
Dividend Yield
2.51%
Price Target
$89.92
Consensus Rating
Buy

Company Overview

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.

MetLife Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
97th Percentile Overall Score

MET MarketRank™: 

MetLife scored higher than 97% of companies evaluated by MarketBeat, and ranked 48th out of 948 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MetLife has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MetLife has only been the subject of 4 research reports in the past 90 days.

  • Read more about MetLife's stock forecast and price target.
  • Earnings Growth

    Earnings for MetLife are expected to grow by 17.75% in the coming year, from $8.17 to $9.62 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MetLife is 17.51, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 104.25.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MetLife is 17.51, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 23.69.

  • Price to Earnings Growth Ratio

    MetLife has a PEG Ratio of 0.64. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    MetLife has a P/B Ratio of 2.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about MetLife's valuation and earnings.
  • Percentage of Shares Shorted

    1.09% of the float of MetLife has been sold short.
  • Short Interest Ratio / Days to Cover

    MetLife has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MetLife has recently decreased by 3.38%, indicating that investor sentiment is improving.
  • Dividend Yield

    MetLife pays a meaningful dividend of 2.51%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    MetLife has been increasing its dividend for 11 years.

  • Dividend Coverage

    The dividend payout ratio of MetLife is 43.95%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, MetLife will have a dividend payout ratio of 22.66% next year. This indicates that MetLife will be able to sustain or increase its dividend.

  • Read more about MetLife's dividend.
  • Percentage of Shares Shorted

    1.09% of the float of MetLife has been sold short.
  • Short Interest Ratio / Days to Cover

    MetLife has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MetLife has recently decreased by 3.38%, indicating that investor sentiment is improving.
  • News Sentiment

    MetLife has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 29 news articles for MetLife this week, compared to 18 articles on an average week.
  • Search Interest

    Only 25 people have searched for MET on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • MarketBeat Follows

    17 people have added MetLife to their MarketBeat watchlist in the last 30 days. This is an increase of 183% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MetLife insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.31% of the stock of MetLife is held by insiders.

  • Percentage Held by Institutions

    94.99% of the stock of MetLife is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MetLife's insider trading history.
Receive MET Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MetLife and its competitors with MarketBeat's FREE daily newsletter.

MET Stock News Headlines

Buy this coin BEFORE Inauguration Day …
Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.
See More Headlines

MET Stock Analysis - Frequently Asked Questions

MetLife's stock was trading at $81.88 at the beginning of the year. Since then, MET shares have increased by 6.0% and is now trading at $86.8270.
View the best growth stocks for 2025 here
.

MetLife, Inc. (NYSE:MET) issued its quarterly earnings results on Wednesday, July, 31st. The financial services provider reported $2.28 EPS for the quarter, beating the consensus estimate of $2.13 by $0.15. The business's revenue for the quarter was up 7.2% compared to the same quarter last year.
Read the conference call transcript
.

MetLife's Board of Directors authorized a stock repurchase program on Wednesday, May 1st 2024, which authorizes the company to buy back $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 6% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board believes its stock is undervalued.

MetLife subsidiaries include these companies: Versant Health, Willing, Logan Circle Partners, American Life Insurance Company, Safeguard Health Enterprises, Grand Bank N.A., General American Life Insurance Company, and more.

Top institutional investors of MetLife include Nordea Investment Management AB (0.61%), Assenagon Asset Management S.A., Janney Montgomery Scott LLC (0.08%) and Wedge Capital Management L L P NC (0.06%). Insiders that own company stock include Steven J Goulart, Ramy Tadros, Marlene Debel, Bill Pappas, Susan M Podlogar and Jeh C Johnson.
View institutional ownership trends
.

Shares of MET stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MetLife investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Exxon Mobil (XOM), Salesforce (CRM) and Verizon Communications (VZ).

Company Calendar

Last Earnings
7/31/2024
Ex-Dividend for 12/16 Dividend
11/05/2024
Dividend Payable
12/16/2024
Today
1/20/2025
Ex-Dividend for 3/11 Dividend
2/04/2025
Next Earnings (Estimated)
2/05/2025
Dividend Payable
3/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Finance
Industry
Life insurance
Sub-Industry
Life & Health Insurance
CUSIP
59156R10
Employees
45,000
Year Founded
1868

Price Target and Rating

Average Stock Price Target
$89.92
High Stock Price Target
$99.00
Low Stock Price Target
$80.00
Potential Upside/Downside
+3.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
12 Analysts

Profitability

Net Income
$1.58 billion
Pretax Margin
7.26%

Debt

Sales & Book Value

Annual Sales
$66.91 billion
Cash Flow
$7.27 per share
Book Value
$40.87 per share

Miscellaneous

Free Float
690,273,000
Market Cap
$60.12 billion
Optionable
Optionable
Beta
1.07

Social Links

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NYSE:MET) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners